O29 Keeping a watchful eye: IgG4-positive lymphoma masquerading as IgG4-related ocular disease

por Man, Yik Long, Hession, Charlie, Rose, Geoffrey, Wilkins, Bridget, Wrench, David, D'Cruz, David
Publicado 2021

Survey of UK histopathology consultants’ attitudes towards academic and molecular pathology

por Brockmoeller, Scarlet, Young, Caroline, Lee, Jessica, Arends, Mark J, Wilkins, Bridget S, Thomas, Gareth J, Oien, Karin A, Jones, Louise, Hunter, Keith D
Publicado 2019

Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features

por Godfrey, Anna L., Campbell, Peter J., MacLean, Cathy, Buck, Georgina, Cook, Julia, Temple, Julie, Wilkins, Bridget S., Wheatley, Keith, Nangalia, Jyoti, Grinfeld, Jacob, McMullin, Mary Frances, Forsyth, Cecily, Kiladjian, Jean-Jacques, Green, Anthony R., Harrison, Claire N.
Publicado 2018

The prognosis of MYC translocation positive diffuse large B‐cell lymphoma depends on the second hit

por Clipson, Alexandra, Barrans, Sharon, Zeng, Naiyan, Crouch, Simon, Grigoropoulos, Nicholas F, Liu, Hongxiang, Kocialkowski, Sylvia, Wang, Ming, Huang, Yuanxue, Worrillow, Lisa, Goodlad, John, Buxton, Jenny, Neat, Michael, Fields, Paul, Wilkins, Bridget, Grant, John W, Wright, Penny, EI‐Daly, Hesham, Follows, George A, Roman, Eve, Watkins, A James, Johnson, Peter W M, Jack, Andrew, Du, Ming‐Qing
Publicado 2015

Different niches for stem cells carrying the same oncogenic driver affect pathogenesis and therapy response in myeloproliferative neoplasms

por Grockowiak, Elodie, Korn, Claudia, Rak, Justyna, Lysenko, Veronika, Hallou, Adrien, Panvini, Francesca M., Williams, Matthew, Fielding, Claire, Fang, Zijian, Khatib-Massalha, Eman, García-García, Andrés, Li, Juan, Khorshed, Reema A., González-Antón, Sara, Baxter, E. Joanna, Kusumbe, Anjali, Wilkins, Bridget S., Green, Anna, Simons, Benjamin D., Harrison, Claire N., Green, Anthony R., Lo Celso, Cristina, Theocharides, Alexandre P. A., Méndez-Ferrer, Simón
Publicado 2023

Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial

por Harrison, Claire N., Nangalia, Jyoti, Boucher, Rebecca, Jackson, Aimee, Yap, Christina, O'Sullivan, Jennifer, Fox, Sonia, Ailts, Isaak, Dueck, Amylou C., Geyer, Holly L., Mesa, Ruben A., Dunn, William G., Nadezhdin, Eugene, Curto-Garcia, Natalia, Green, Anna, Wilkins, Bridget, Coppell, Jason, Laurie, John, Garg, Mamta, Ewing, Joanne, Knapper, Steven, Crowe, Josephine, Chen, Frederick, Koutsavlis, Ioannis, Godfrey, Anna, Arami, Siamak, Drummond, Mark, Byrne, Jennifer, Clark, Fiona, Mead-Harvey, Carolyn, Baxter, Elizabeth Joanna, McMullin, Mary Frances, Mead, Adam J.
Publicado 2023